| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Angioplasty, Balloon, Coronary | 8 | 2012 | 39 | 1.870 |
Why?
|
| Stents | 7 | 2010 | 75 | 1.490 |
Why?
|
| Heart-Assist Devices | 6 | 2012 | 18 | 1.490 |
Why?
|
| Cardiac Catheterization | 6 | 2017 | 55 | 1.130 |
Why?
|
| Coronary Stenosis | 5 | 2010 | 16 | 1.080 |
Why?
|
| Myocardial Infarction | 6 | 2022 | 125 | 1.060 |
Why?
|
| Coronary Angiography | 10 | 2023 | 68 | 1.020 |
Why?
|
| Intra-Aortic Balloon Pumping | 3 | 2010 | 5 | 0.970 |
Why?
|
| Coronary Artery Disease | 4 | 2023 | 124 | 0.910 |
Why?
|
| Heart Failure | 3 | 2022 | 141 | 0.770 |
Why?
|
| Angioplasty, Balloon | 3 | 2011 | 14 | 0.720 |
Why?
|
| Aorta | 2 | 2011 | 16 | 0.650 |
Why?
|
| Pulmonary Embolism | 4 | 2008 | 55 | 0.630 |
Why?
|
| Aortic Valve Stenosis | 4 | 2023 | 18 | 0.620 |
Why?
|
| Thrombectomy | 3 | 2008 | 30 | 0.590 |
Why?
|
| Humans | 42 | 2023 | 22823 | 0.580 |
Why?
|
| Percutaneous Coronary Intervention | 3 | 2023 | 20 | 0.560 |
Why?
|
| Transcatheter Aortic Valve Replacement | 3 | 2023 | 15 | 0.560 |
Why?
|
| Heart Transplantation | 3 | 2010 | 30 | 0.550 |
Why?
|
| Aortic Valve | 4 | 2023 | 22 | 0.510 |
Why?
|
| Coronary Vessels | 3 | 2017 | 33 | 0.510 |
Why?
|
| Thrombosis | 2 | 2022 | 51 | 0.510 |
Why?
|
| Treatment Outcome | 16 | 2023 | 2934 | 0.500 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 29 | 0.480 |
Why?
|
| Aneurysm, False | 2 | 2007 | 6 | 0.480 |
Why?
|
| Cardiology | 1 | 2016 | 44 | 0.470 |
Why?
|
| Hemodynamics | 3 | 2010 | 53 | 0.460 |
Why?
|
| Diastole | 4 | 2010 | 27 | 0.450 |
Why?
|
| Shock, Cardiogenic | 2 | 2012 | 8 | 0.410 |
Why?
|
| Whole Blood Coagulation Time | 2 | 2012 | 3 | 0.380 |
Why?
|
| Subclavian Artery | 2 | 2010 | 3 | 0.380 |
Why?
|
| Coronary Disease | 1 | 2012 | 49 | 0.360 |
Why?
|
| Drug-Eluting Stents | 2 | 2022 | 14 | 0.360 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 64 | 0.360 |
Why?
|
| Atrial Fibrillation | 2 | 2017 | 97 | 0.350 |
Why?
|
| Fibrinolytic Agents | 2 | 2011 | 57 | 0.340 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 24 | 0.340 |
Why?
|
| Calcinosis | 2 | 2010 | 43 | 0.340 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 2 | 2007 | 4 | 0.340 |
Why?
|
| Point-of-Care Systems | 1 | 2012 | 58 | 0.340 |
Why?
|
| Foreign-Body Migration | 2 | 2008 | 18 | 0.340 |
Why?
|
| Male | 21 | 2021 | 12400 | 0.340 |
Why?
|
| Pericardium | 1 | 2010 | 20 | 0.330 |
Why?
|
| Hypertensive Encephalopathy | 1 | 2010 | 1 | 0.330 |
Why?
|
| Renal Artery Obstruction | 1 | 2010 | 3 | 0.330 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2009 | 12 | 0.330 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2010 | 2 | 0.320 |
Why?
|
| Cardiotonic Agents | 1 | 2010 | 9 | 0.320 |
Why?
|
| Vena Cava, Superior | 1 | 2010 | 1 | 0.320 |
Why?
|
| Angioplasty | 1 | 2010 | 5 | 0.320 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2010 | 4 | 0.320 |
Why?
|
| Balloon Occlusion | 2 | 2007 | 8 | 0.320 |
Why?
|
| Artifacts | 2 | 2009 | 29 | 0.320 |
Why?
|
| Pericarditis, Constrictive | 1 | 2010 | 1 | 0.320 |
Why?
|
| Foramen Ovale, Patent | 1 | 2010 | 2 | 0.320 |
Why?
|
| Hepatic Veins | 1 | 2010 | 10 | 0.320 |
Why?
|
| Coronary Artery Bypass | 2 | 2007 | 24 | 0.320 |
Why?
|
| Heart Diseases | 1 | 2010 | 56 | 0.320 |
Why?
|
| Echocardiography, Doppler | 1 | 2009 | 16 | 0.310 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2010 | 36 | 0.310 |
Why?
|
| Coronary Circulation | 1 | 2009 | 27 | 0.310 |
Why?
|
| Blood Pressure | 1 | 2009 | 166 | 0.290 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2022 | 30 | 0.280 |
Why?
|
| Coronary Aneurysm | 1 | 2007 | 1 | 0.270 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2007 | 10 | 0.270 |
Why?
|
| Vascular Surgical Procedures | 1 | 2007 | 23 | 0.270 |
Why?
|
| Female | 15 | 2021 | 12904 | 0.270 |
Why?
|
| Mammary Arteries | 1 | 2007 | 8 | 0.270 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2023 | 7 | 0.270 |
Why?
|
| Coronary Thrombosis | 1 | 2007 | 6 | 0.260 |
Why?
|
| Thrombolytic Therapy | 1 | 2007 | 44 | 0.260 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2023 | 24 | 0.260 |
Why?
|
| Aged | 12 | 2021 | 7412 | 0.250 |
Why?
|
| Transducers, Pressure | 1 | 2006 | 4 | 0.250 |
Why?
|
| Ventricular Pressure | 1 | 2006 | 2 | 0.250 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2010 | 572 | 0.240 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 3717 | 0.220 |
Why?
|
| Postoperative Complications | 1 | 2010 | 810 | 0.220 |
Why?
|
| Middle Aged | 11 | 2011 | 7873 | 0.220 |
Why?
|
| Heart Aneurysm | 1 | 2004 | 6 | 0.210 |
Why?
|
| Adult | 9 | 2017 | 6896 | 0.190 |
Why?
|
| Hypotension | 1 | 2022 | 20 | 0.190 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2012 | 9 | 0.180 |
Why?
|
| Conservative Treatment | 1 | 2021 | 15 | 0.170 |
Why?
|
| Computed Tomography Angiography | 2 | 2017 | 27 | 0.170 |
Why?
|
| Catheterization | 3 | 2010 | 40 | 0.160 |
Why?
|
| Health Resources | 1 | 2019 | 21 | 0.160 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 21 | 0.160 |
Why?
|
| Follow-Up Studies | 3 | 2007 | 1412 | 0.150 |
Why?
|
| Retrospective Studies | 3 | 2023 | 2976 | 0.150 |
Why?
|
| Risk Assessment | 4 | 2021 | 546 | 0.150 |
Why?
|
| Network Meta-Analysis | 3 | 2023 | 22 | 0.150 |
Why?
|
| Constriction, Pathologic | 3 | 2010 | 27 | 0.140 |
Why?
|
| Risk Factors | 5 | 2023 | 1966 | 0.140 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2007 | 31 | 0.140 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2017 | 1 | 0.140 |
Why?
|
| Azygos Vein | 1 | 2017 | 3 | 0.140 |
Why?
|
| Incidental Findings | 1 | 2017 | 11 | 0.140 |
Why?
|
| Vena Cava, Inferior | 1 | 2017 | 9 | 0.140 |
Why?
|
| Atrial Appendage | 1 | 2017 | 26 | 0.130 |
Why?
|
| Phlebography | 3 | 2017 | 9 | 0.130 |
Why?
|
| Punctures | 2 | 2010 | 9 | 0.130 |
Why?
|
| Exercise Test | 1 | 2017 | 112 | 0.130 |
Why?
|
| Femoral Artery | 1 | 2016 | 5 | 0.120 |
Why?
|
| Radial Artery | 1 | 2016 | 6 | 0.120 |
Why?
|
| Stroke Volume | 2 | 2022 | 41 | 0.120 |
Why?
|
| Hemorrhage | 2 | 2022 | 73 | 0.120 |
Why?
|
| Heart Ventricles | 2 | 2008 | 82 | 0.120 |
Why?
|
| Saphenous Vein | 2 | 2007 | 5 | 0.120 |
Why?
|
| Aortic Rupture | 2 | 2003 | 5 | 0.100 |
Why?
|
| Sinus of Valsalva | 2 | 2003 | 3 | 0.100 |
Why?
|
| Aortic Aneurysm | 2 | 2003 | 10 | 0.100 |
Why?
|
| Bayes Theorem | 2 | 2023 | 32 | 0.100 |
Why?
|
| Death | 2 | 2023 | 39 | 0.100 |
Why?
|
| Erectile Dysfunction | 1 | 2013 | 53 | 0.090 |
Why?
|
| Severity of Illness Index | 2 | 2023 | 795 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 591 | 0.090 |
Why?
|
| Angina, Unstable | 2 | 2009 | 9 | 0.090 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 28 | 0.090 |
Why?
|
| Echocardiography | 2 | 2008 | 67 | 0.080 |
Why?
|
| Prosthesis Design | 2 | 2009 | 388 | 0.080 |
Why?
|
| Peptides | 1 | 2011 | 89 | 0.080 |
Why?
|
| Heart Arrest | 1 | 2011 | 39 | 0.080 |
Why?
|
| Hypertension, Renal | 1 | 2010 | 3 | 0.080 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2010 | 40 | 0.080 |
Why?
|
| Pericardiectomy | 1 | 2010 | 1 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 290 | 0.080 |
Why?
|
| Hemostatic Techniques | 1 | 2010 | 5 | 0.080 |
Why?
|
| Septal Occluder Device | 1 | 2010 | 6 | 0.080 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2010 | 64 | 0.080 |
Why?
|
| Ventricular Function, Right | 1 | 2009 | 3 | 0.080 |
Why?
|
| Cardiac Output | 1 | 2009 | 12 | 0.080 |
Why?
|
| Treatment Failure | 1 | 2010 | 126 | 0.080 |
Why?
|
| Ventricular Function, Left | 1 | 2009 | 34 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 294 | 0.080 |
Why?
|
| Acute Disease | 1 | 2009 | 162 | 0.070 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2008 | 3 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2009 | 242 | 0.070 |
Why?
|
| Vena Cava Filters | 1 | 2008 | 7 | 0.070 |
Why?
|
| Gastrectomy | 1 | 2008 | 28 | 0.070 |
Why?
|
| Remission, Spontaneous | 1 | 2007 | 8 | 0.070 |
Why?
|
| Thoracotomy | 1 | 2007 | 30 | 0.070 |
Why?
|
| Angiography | 1 | 2007 | 25 | 0.070 |
Why?
|
| Chest Pain | 1 | 2007 | 20 | 0.070 |
Why?
|
| Heart Valve Prosthesis | 1 | 2007 | 12 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2007 | 92 | 0.060 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2006 | 2 | 0.060 |
Why?
|
| Heart Valve Diseases | 1 | 2006 | 11 | 0.060 |
Why?
|
| Mitral Valve | 1 | 2006 | 8 | 0.060 |
Why?
|
| Image Enhancement | 1 | 2006 | 42 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2006 | 152 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2006 | 59 | 0.060 |
Why?
|
| Hospital Mortality | 2 | 2019 | 129 | 0.050 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2004 | 19 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2004 | 50 | 0.050 |
Why?
|
| Child | 1 | 2007 | 1153 | 0.050 |
Why?
|
| Tomography, Optical Coherence | 1 | 2023 | 13 | 0.050 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2003 | 20 | 0.050 |
Why?
|
| Receptors, Angiotensin | 1 | 2022 | 3 | 0.050 |
Why?
|
| Neprilysin | 1 | 2022 | 7 | 0.050 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2022 | 6 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 16 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2023 | 64 | 0.050 |
Why?
|
| Brachial Artery | 1 | 2002 | 6 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2022 | 40 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2022 | 38 | 0.050 |
Why?
|
| Health Status | 1 | 2023 | 200 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2022 | 162 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2002 | 112 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 243 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2019 | 57 | 0.040 |
Why?
|
| Quality of Life | 1 | 2023 | 559 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 113 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2019 | 147 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2019 | 307 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2019 | 364 | 0.040 |
Why?
|
| Length of Stay | 1 | 2019 | 298 | 0.030 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2017 | 8 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 309 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 1258 | 0.030 |
Why?
|
| Device Removal | 2 | 2008 | 68 | 0.030 |
Why?
|
| United States | 1 | 2019 | 1762 | 0.030 |
Why?
|
| Contrast Media | 1 | 2008 | 59 | 0.020 |
Why?
|
| Comorbidity | 1 | 2008 | 426 | 0.020 |
Why?
|
| Obesity, Morbid | 1 | 2008 | 96 | 0.020 |
Why?
|
| Computer Systems | 1 | 2006 | 7 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 190 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 439 | 0.010 |
Why?
|
| Prolapse | 1 | 2003 | 1 | 0.010 |
Why?
|
| Heart Atria | 1 | 2003 | 22 | 0.010 |
Why?
|
| Aortography | 1 | 2003 | 5 | 0.010 |
Why?
|
| Body Surface Area | 1 | 2002 | 3 | 0.010 |
Why?
|
| Equipment Safety | 1 | 2002 | 6 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2002 | 27 | 0.010 |
Why?
|